Curaleaf Holdings (CURLF) Cash & Equivalents (2019 - 2025)

Curaleaf Holdings (CURLF) has reported Cash & Equivalents for 7 consecutive years, with $101.6 million the latest figure, recorded in Q4 2025.

• Quarterly Cash & Equivalents fell 5.27% year-over-year to $101.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $101.6 million (down 5.27% YoY) and the FY2025 annual result came in at $101.6 million, down 5.27% from the prior year.
• Cash & Equivalents eased to $101.6 million in Q4 2025 per CURLF's latest filing, from $107.2 million in the prior quarter.
• Over the last five years, Cash & Equivalents for CURLF reached as high as $333.8 million in Q2 2021 and fell as low as $73.5 million in Q4 2021.
• A 5-year average of $163.7 million and a median of $107.2 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2021 — Cash & Equivalents jumped 274.99% — and 2023, when it tumbled 43.73%.
• Year by year, Cash & Equivalents stood at $73.5 million in 2021, then surged by 121.88% to $163.2 million in 2022, then slumped by 43.73% to $91.8 million in 2023, then advanced by 16.78% to $107.2 million in 2024, then fell by 5.27% to $101.6 million in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $101.6 million, $107.2 million, and $90.0 million for Q4 2025, Q4 2024, and Q3 2024 respectively.